Because ovarian cancer cell grow in the peritoneal cavity, secreted IL6 is likely to initiate its own cascades of oncogenic pathways, further highlighting the significance of ovarian cancer-TME interactions. This evidence concerns the gene IL6 and ovarian carcinoma.